APOE information and its role in cholesterol metabolism, how to influence its levels
Apolipoprotein E (APOE) plays a central role in VLDL cholesterol metabolism. Both APOE e4 allele (APOE4) and C-reactive protein (CRP) are associated with greater risk of dementia and vascular disease, but APOE4 carriers have lower blood concentrations of CRP than do noncarriers, possibly through a mechanism favoring the clearance of the CRP VLDL-bound fraction. Homocysteine, another risk factor for vascular disease and dementia, also binds to VLDL in blood. However, the association between APOE4 and hyperhomocysteinemia has never been thoroughly investigated. We investigated in an elderly population whether 1) APOE4 is associated with hyperhomocysteinemia [plasma total homocysteine (tHcy) > 15 mumol/L], 2) hyperhomocysteinemia affects the association between APOE4 and high CRP (serum CRP > 3 mg/L), and 3) B vitamin status affects these associations. APOE4 genotypes were assessed and tHcy, CRP, and serum concentrations of folate and vitamin B-12 were measured in 671 cognitively healthy subjects (52% women; mean age: 73 y) from an Italian population-based prospective cohort study. APOE4 carriers without high CRP had a lower risk of hyperhomocysteinemia than did noncarriers.
Independently from B vitamin status, APOE4 carriers have a lower risk of hyperhomocysteinemia and of high CRP than do noncarriers, but the presence of one condition attenuates the association of APOE4 with the other condition.
APOE gene function and role
The APOE gene gives instructions for making a protein called apolipoprotein E.
This protein combines with fats (lipids) in the body to form molecules called
lipoproteins. Apolipoprotein E is a major component of a specific type of
lipoprotein called very low-density lipoproteins (VLDLs). VLDLs remove excess
cholesterol from the blood and carry it to the liver for processing. Maintaining
normal levels of cholesterol is essential for the prevention of conditions that
affect the heart and blood vessels (cardiovascular diseases), including heart
attack and stroke.
back to yohimbe bark product